Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice

BACKGROUND: Postmenopausal osteoporosis (PMO) is common among women over 50 years of age and is associated with an increased risk of fracture. Bone-targeted agents, such as denosumab, can reduce fracture risk in patients with PMO. OBJECTIVE: The aim was to describe baseline characteristics and chang...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyanov, Mihail, Shinkov, Alexander, Psachoulia, Emi, Intorcia, Michele, Petkova, Reneta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318327/
https://www.ncbi.nlm.nih.gov/pubmed/27988913
http://dx.doi.org/10.1007/s40268-016-0159-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318327/
https://www.ncbi.nlm.nih.gov/pubmed/27988913
http://dx.doi.org/10.1007/s40268-016-0159-3

Ejemplares similares